Helicure Overview

  • Founded
  • 2005
  • Status
  • Private
  • Employees
  • 1
  • Latest Deal Type
  • IBO

Helicure General Information


Developer of vaccines to protect against gastric cancer and ulcer disease, caused by Helicobacter pylori. The company's treatment concept is based on therapeutic immunization of infected patients with chronic dyspepsia.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Box 7997
  • 907 19 Umeå
  • Sweden
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Helicure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. IBO 13-Jun-2013 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view Helicure’s complete valuation and funding history, request access »

Helicure Executive Team (3)

Name Title Board Seat Contact Info
Thomas Borén Ph.D Co-Founder, Co-Owner, Board Member, Chief Executive Officer & Chief Scientific Officer
Lennart Hammarström Co-Founder & Co-Owner
You’re viewing 2 of 3 executive team members. Get the full list »

Helicure Board Members (4)

Name Representing Role Since
Bo Hammarström Self Board Member 000 0000
Jacob Odeberg MD Self Board Member 000 0000
Per-Olof Gunnesson Self Chairman 000 0000
Thomas Borén Ph.D Helicure Co-Founder, Co-Owner, Board Member, Chief Executive Officer & Chief Scientific Officer 000 0000
To view Helicure’s complete board members history, request access »

Helicure Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial